Clinical Trials in Washington D.C.

Washington D.C. is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Washington D.C. and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 131 actively recruiting studies with Washington D.C. sites out of 131 registered in total. The busiest research areas in Washington D.C. are Breast Cancer, Carcinoma, Non-Small-Cell Lung, Sickle Cell Disease. Leading sponsors running trials in the state include Georgetown University, National Cancer Institute (NCI), AstraZeneca. By stage, Washington D.C. trials break down as Phase 1 (14), Phase 2 (34), Phase 3 (43), Phase 4 (2).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Frequently Asked Questions — Clinical Trials in Washington D.C.